论文信息 - Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design. - 字舞流文

Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.

P. Ascierto | J. Larkin | M. Sznol | G. Long | W. J. Geese | N. Khushalani | S. Sandhu | A. Diab | P. Statkevich | A. Jarkowski | Ming Zhou | H. Koon | W. Geese